U.S. market Closed. Opens in 10 hours 6 minutes

NMTC | NeuroOne Medical Technologies Corporation Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.9283 - 0.9927
52 Week Range 0.6020 - 2.0000
Beta 0.80
Implied Volatility 574.42%
IV Rank 100.00%
Day's Volume 47,444
Average Volume 60,129
Shares Outstanding 30,811,900
Market Cap 28,602,687
Sector Healthcare
Industry Medical - Devices
IPO Date 2018-03-15
Valuation
Profitability
Growth
Health
P/E Ratio -1.93
Forward P/E Ratio N/A
EPS -0.48
1YR Price Target 2.62
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 16
Country USA
Website NMTC
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram(cEEG) and stereoelectrocencephalography(sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders.
*Chart delayed
Analyzing fundamentals for NMTC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is very weak. For more detailed analysis please see NMTC Fundamentals page.

Watching at NMTC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on NMTC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙